MRL VENTURES FUND
The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly differentiated new medicines to improve human health.
MRL VENTURES FUND
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Status:
Active
Total Funding:
16 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Nginx Amazon DMARC Amazon SSL Amazon CloudFront AWS Global Accelerator ATT DNS
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
aMoon Fund
aMoon is a leading healthtech & life sciences venture capital firm.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Levianix LLC
Levianix, an alternative asset management fund, serves as a private-sector bailout of the mental and behavioral healthcare industry.
MaRS Discovery District
MaRS is a non-profit organization that partners with entrepreneurs, researchers, business and government.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
MorganFranklin Consulting
MorganFranklin is a strategy and execution-focused business consulting firm and professional advisor.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Current Advisors List
Board_member
Current Employees Featured
Reza Halse Partner @ MRL Ventures Fund
Partner
2017-01-01
Christine Brennan Partner @ MRL Ventures Fund
Partner
2017-06-01
Peter Dudek Partner @ MRL Ventures Fund
Partner
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Photys Therapeutics | MRL Ventures Fund investment in Series A - Photys Therapeutics | 75 M USD |
| 2022-08-25 | Aktis Oncology | MRL Ventures Fund investment in Series A - Aktis Oncology | 84 M USD |
| 2022-03-23 | LifeMine Therapeutics | MRL Ventures Fund investment in Series C - LifeMine Therapeutics | 175 M USD |
| 2022-02-22 | Eyebiotech | MRL Ventures Fund investment in Series A - Eyebiotech | 65 M USD |
| 2022-01-06 | AmbAgon Therapeutics | MRL Ventures Fund investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-10-26 | Mozart Therapeutics | MRL Ventures Fund investment in Series A - Mozart Therapeutics | 55 M USD |
| 2021-07-15 | PAQ Therapeutics | MRL Ventures Fund investment in Series A - PAQ Therapeutics | 30 M USD |
| 2021-05-10 | Therini Bio | MRL Ventures Fund investment in Seed Round - Therini Bio | 17 M USD |
| 2021-03-31 | Entrada Therapeutics | MRL Ventures Fund investment in Series B - Entrada Therapeutics | 116 M USD |
| 2021-03-01 | Carisma Therapeutics | MRL Ventures Fund investment in Series B - Carisma Therapeutics | 12 M USD |
More informations about "MRL Ventures Fund"
MRL Ventures Fund - Crunchbase Investor Profile
The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early …See details»
MRL Ventures Fund - Investments, Portfolio & Company Exits
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund. New. Resources. ... MRL Ventures Fund has made 11 diversity investments. Their most recent …See details»
MRL Ventures Fund LLC (MRLV) - Life-Sciences-Europe.com
May 23, 2018 MRL Ventures Fund (MRLV) is the therapeutics-focused early-stage corporate venture fund of MSD. MSD is a trade name of Merck & Co., Inc., with headquarters in …See details»
MRL Ventures Fund investment portfolio | PitchBook
MRL Ventures Fund's latest investment was on 30-Oct-2024 in Axonis Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting …See details»
MRL Ventures Fund - Org Chart, Teams, Culture & Jobs - The Org
MRL Ventures Fund (MRLV) invests in innovative therapeutics companies that are developing transformative medicines that have the potential to meaningfully improve the lives of patients. …See details»
MRL Ventures Fund - Funding, Financials, Valuation & Investors
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. ... How much funding …See details»
MRL Ventures Fund - Massinvestor Venture Capital and Private …
MRL Ventures Fund is a corporate venture fund for Merck, and is actively developing a portfolio of early-stage therapeutic companies, which are focused on delivering innovative therapies to …See details»
MRL Ventures Fund: Performance - PitchBook
MRL Ventures Fund is an early-stage venture capital fund managed by MRL Ventures Fund. The fund is located in Cambridge, Massachusetts. The fund targets the healthcare sector.See details»
MRL Ventures Fund - Investor in Cambridge, Massachusetts - Ask …
The MRL Ventures Fund (MRLV) team invests globally in early-stage, preclinical therapeutics companies to transform patient care. The MRL Ventures Fund (MRLV) is the corporate …See details»
MRL Ventures Fund - teaserclub.com
The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL …See details»
MRL Ventures Fund - venturecapitalarchive.com
The MRL Ventures Fund (MRLV) is the corporate venture arm of Merck & Co., Inc., located in Cambridge, MA. The MRLV team, comprising experienced lifesciences venture Capital …See details»
MRL Ventures Fund – Investors Database - Unicorn Nest
The fund is generally included in 2-6 deals every year. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this MRL …See details»
MRL Ventures Fund - vcinvestorlist.com
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund. Number of Investments: 46 Number of Exits: 13 Investment Industries: Biotechnology;Health Care …See details»
MRL Ventures Fund - SPEEDA Edge
MRL Ventures Fund (MRLV) is the therapeutics-focused corporate venture fund of Merck & Co., Inc., headquartered in Cambridge, Massachusetts. The fund invests globally in early-stage …See details»
MRL Ventures Fund Investor Information - Funding, Portfolio …
MRL Ventures Fund LLC, based in Delaware, invests in early-stage companies, particularly at the Series A level, with check sizes ranging from $500,000 to $10,000,000. Concentrating on the …See details»
Welcome to Startup Virginia - Startup Virginia
We are the region’s only non-profit organization serving startup founders, entrepreneurs, and innovators at any ... fund, and grow their businesses. $406M. Revenue Earned. $272M. …See details»
MRL Ventures Fund - Contacts, Employees, Board Members
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. ... MRL …See details»
Corporate Venturing - Harvard Business Review
So in 2001 the company launched a corporate venture-capital fund in order to engage with cutting-edge biotech firms when they were just start-ups. By 2013, Lilly Ventures had been …See details»
Fortuna Future Ventures: Funding the Next Trillion-Dollar …
18 hours ago United States, March 26, 2025-- Fortuna Future Ventures is launching a venture fund and is looking for investors to be a part of it. The fund aims to help early-stage companies …See details»
Meet the 2025 Access Ventures Fellows — Access Ventures
2 days ago In 2025, the organization will serve nearly 3,000 people experiencing homelessness across 30 cities in California. This summer, Zac will graduate with a master’s in urban planning …See details»